Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study assesses the safety, tolerability, and PK/PD of HEC-007 Injection in healthy subjects and overweight/obese participants; the trial is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HEC-007 Injection (HEC-007)

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Healthy Subjects | Phase 1 | Status: NOT_YET_RECRUITING